Comparing Ketoconazole Topical vs Terbinafine
| Ketoconazole topical | Terbinafine |
|
|---|
| Ketoconazole topical | Terbinafine |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription and OTC
Prescribed for Seborrheic Dermatitis, Cutaneous Candidiasis, Dandruff, Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Versicolor. May also be prescribed off label for Androgenetic Alopecia. |
Prescription only
Prescribed for Onychomycosis - Toenail, Tinea Capitis, Cutaneous Candidiasis, Onychomycosis - Fingernail, Tinea Corporis, Tinea Cruris, Tinea Pedis. terbinafine may also be used for purposes not... View more |
Related suggestions Tinea Corporis
Cutaneous Candidiasis
Tinea Pedis
Tinea Cruris
|
|||||||||||||||
| More about Ketoconazole topical | More about Terbinafine | ||||||||||||||||
| Generic Status | |||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Ketoconazole topical has an average rating of 6.9 out of 10 from a total of 40 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 29% reported a negative effect. |
Terbinafine has an average rating of 6.4 out of 10 from a total of 462 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See also: ketoconazole topical side effects in more detail. |
Commonly reported side effects include:
See also: terbinafine side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all ketoconazole topical prices |
View all terbinafine prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Extina, Ketodan, Kuric, Nizoral A-D, Nizoral Shampoo, Nizoral Topical, Xolegel | Lamisil, Terbinex | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
N/A |
200 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 143 drugs are known to interact with terbinafine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 31, 1985 |
May 10, 1996 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.